Detalhe da pesquisa
1.
SARS-CoV-2 infection in high-risk children following tixagevimab-cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study.
Front Oncol
; 13: 1229655, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601666
2.
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.
EBioMedicine
; 80: 104065, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598441
3.
Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Lancet Infect Dis
; 20(8): 964-975, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275867